alexa Amar B. Singh | Stanford University
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Amar B. Singh

Amar B. Singh Amar Bahadur Singh
Research Associate
Veterans Affairs Palo Alto Health Care System/
Palo Alto Veterans Institute for Research

Dr. Amar B. Singh received his Ph.D. in Biochemistry, area of specialization was Biochemical and Molecular Targets of Novel Antidiabetic Agents from Central Drug Research Institute Lucknow affiliated with Jawaharlal Nehru University, New Delhi for Ph.D. program. During his Ph.D., he was selected for Senior Research Fellowship award sponsored by Council of Scientific and Industrial Research, New Delhi. He was postdoctoral fellow in Molecular Cardiology at Texas A&M Health Science Center, College of Medicine, under Prof. Kenneth M. Baker. His second postdoctoral training in Endocrinology, Gerontology and Metabolism at School of medicine, Stanford University under Prof. Fredric B. Kraemer. Dr. Singh currently a Research Associate in Endocrinology at Stanford affiliated VA Palo Alto Health Care System, Palo Alto, California. Dr. Singh have been doing research last 10 years and he has made a significant contribution in the area of diabetes, diabetic cardiomyopathy and hypercholesterolemia. He has published 35 research articles in prestigious journal, 15 abstract and conference presentation, and 3 patents.

Research Interest

Hypercholesterolemia, Diabetes, Diabetic Cardiomyopathy, Molecular Biology, Post-transcriptional regulation of LDL receptor mRNA stability, New drug discovery R&D on Diabetes, Dyslipidemia and Cardiovascular diseases.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version